Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA

BACKGROUND: Prostate-specific antigen (PSA) is widely used for prostate cancer screening, but low specificity results in high false positive rates of prostate biopsies. OBJECTIVE: To develop new risk assessment models to overcome the diagnostic limitation of PSA and reduce unnecessary prostate biops...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Zhao, Jing, Liu, Shuai, Gao, Dexuan, Ding, Sentai, Niu, Zhihong, Zhang, Hui, Huang, Zhilong, Qiu, Juhui, Li, Qing, Li, Ning, Xie, Fang, Cui, Jilei, Lu, Jiaju
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354782/
https://ncbi.nlm.nih.gov/pubmed/28039477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14214
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados